Tagara, S.; Valsami, S.; Gavriilaki, E.; Kyriakou, E.; Grouzi, E.; Evangelidis, P.; Karvouni, P.; Kaiafa, G.; Papadakis, I.; Poulis, A.;
et al. Activated Complement System’s Impact in Antiphospholipid Syndrome Thrombosis: From Pathophysiology to Treatment. J. Clin. Med. 2025, 14, 6672.
https://doi.org/10.3390/jcm14186672
AMA Style
Tagara S, Valsami S, Gavriilaki E, Kyriakou E, Grouzi E, Evangelidis P, Karvouni P, Kaiafa G, Papadakis I, Poulis A,
et al. Activated Complement System’s Impact in Antiphospholipid Syndrome Thrombosis: From Pathophysiology to Treatment. Journal of Clinical Medicine. 2025; 14(18):6672.
https://doi.org/10.3390/jcm14186672
Chicago/Turabian Style
Tagara, Sofia, Serena Valsami, Eleni Gavriilaki, Elias Kyriakou, Elisavet Grouzi, Paschalis Evangelidis, Paraskevi Karvouni, Georgia Kaiafa, Ioannis Papadakis, Aristarchos Poulis,
and et al. 2025. "Activated Complement System’s Impact in Antiphospholipid Syndrome Thrombosis: From Pathophysiology to Treatment" Journal of Clinical Medicine 14, no. 18: 6672.
https://doi.org/10.3390/jcm14186672
APA Style
Tagara, S., Valsami, S., Gavriilaki, E., Kyriakou, E., Grouzi, E., Evangelidis, P., Karvouni, P., Kaiafa, G., Papadakis, I., Poulis, A., Petrou, E., Politou, M., & Kokoris, S.
(2025). Activated Complement System’s Impact in Antiphospholipid Syndrome Thrombosis: From Pathophysiology to Treatment. Journal of Clinical Medicine, 14(18), 6672.
https://doi.org/10.3390/jcm14186672
